Mumbai-based Speciality Medicines Limited opens its ₹29.14 crore SME IPO on March 20, 2026. With a massive revenue surge to ₹58 crore and a transition from a simple distributor to an R&D-driven pharma player, the company is attracting eyeballs. Priced at ₹117–₹124, we analyze if the strong FY25 financials and low debt make this a "Subscribe" for your long-term portfolio.
The ₹1,842 crore IPO of Central Mine Planning & Design Institute (CMPDI) opens for public subscription on March 20, 2026. As a "Mini Ratna" with a 61% market share in coal consultancy, this debt-free PSU is drawing eyes with its 36.7% ROE. Priced at ₹163–₹172, we break down why the "smart money" just poured in and what the ₹11–₹22 GMP signals for retail investors.
The ₹400 crore GSP Crop Science IPO reaches its conclusion today, March 18, 2026. With institutional (QIB) and high-net-worth (NII) categories already comfortably over the finish line, the total subscription has crossed the 1x mark. However, with a ₹0 Grey Market Premium and a quiet retail segment, we analyze if this is a value-buy for the long term.
Gurgaon-based Novus Loyalty is in the middle of its ₹60.15 crore SME IPO (March 17–20, 2026). Following a Day 1 subscription of 0.83x, the issue is seeing a steady climb today. While the Grey Market Premium (GMP) remains flat at ₹0, the company’s recent profit jump in H1 FY26 is drawing the attention of long-term risk-seekers. We break down the Day 2 pulse and the "aggressive" vs. "value" pricing debate.
The ₹306 crore Innovision Limited IPO officially closes today, March 17, 2026. After a slow start led to a revised price band of ₹494–₹519 and a 5-day extension, institutional investors have finally moved in. With the overall subscription crossing 1.2x and a recovering GMP, we look at the final numbers before the window shuts at 5:00 PM.
Gurgaon-based Novus Loyalty launched its ₹60.15 crore SME IPO today, March 17, 2026. With a price band of ₹139–₹146, the company is leveraging its AI-powered platform to serve giants in fintech and banking. This blog covers the Day 1 subscription start, the impressive 40% ROCE, and why the grey market is currently playing it cool.
Ahmedabad-based GSP Crop Science is currently in the middle of its ₹400 crore mainboard IPO (March 16–18, 2026). While the issue saw a solid 47% subscription on its opening day—driven primarily by institutional interest—the grey market remains flat. We break down the Day 2 pulse, the 18x valuation, and whether the debt-reduction strategy makes it a long-term winner.
Gurgaon-based Innovision Limited has extended its ₹306 crore IPO until March 17, 2026, after a tepid initial response. To sweeten the deal, the company has slashed its price band to ₹494–₹519. With a high ROE of 35% but heavy reliance on NHAI contracts, we break down if this revised valuation makes it a better bet for your portfolio.
Gurgaon-based Novus Loyalty Limited is set to launch its ₹60.15 crore SME IPO on March 17, 2026. Specializing in AI-powered loyalty platforms for giants in the Fintech and Banking sectors, the company has seen its revenue soar to over ₹100 crore. With a price band of ₹139–₹146, we look at whether this "low-margin, high-growth" tech play belongs in your portfolio.
Gujarat-based GSP Crop Science launched its ₹400 crore mainboard IPO today, March 16, 2026. With a price band of ₹304–₹320, the company is showcasing an incredible 360% profit surge since FY23. This blog breaks down the Day 1 subscription pulse, the ₹170 crore debt-reduction plan, and why analysts are keeping a "Neutral" but watchful eye on this agrochemical giant.
Precision engineering firm Apsis Aerocom Limited has launched its ₹35.77 crore SME IPO today, March 11, 2026. With a price band of ₹104–₹110 and a massive 182% jump in profits for FY25, the company is attracting eyes in the defense and healthcare manufacturing space. But with an entry barrier of ₹2.64 lakh, is the growth sustainable?
Gurgaon-based Innovision Limited is currently in the middle of its ₹323 crore mainboard IPO (March 10–12, 2026). As a major player in manpower services and NHAI toll management, the company boasts a massive 35% ROE. However, with a ₹0 Grey Market Premium and heavy reliance on government contracts, investors are weighing its 32x P/E valuation against the risks of a labor-intensive business model.
GMP IPO Watch
Open IPO
